Europe Viscosupplementation market

Eastern-europe accounted for the largest market share in 2017 in the europe viscosupplementation market, and is expected to reach usd 93.73 million in 2023 from usd 72.75 million in 2017. however, italy is the fastest growing market, which is expected to grow at a cagr of 6.59% during the forecast period 2018 - 2023. knee arthritis segment accounted for the largest market share in 2017, this market is expected to reach usd 253.12 million in 2023 from usd 189.14 million in 2017. this market is projected to grow at a cagr of 4.96% during the forecast period from 2018 - 2023. however, hip osteoarthritis segment is the fastest growing market, which is expected to grow at a cagr of 6.22% during the forecast period 2018 - 2023. hospitals and clinics segment accounted for the largest market share in 2017, this market is expected to reach usd 266.07 million in 2023 from usd 195.14 million in 2017. this market is projected to grow at a cagr of 5.35% during the forecast period from 2018 - 2023. however, ambulatory surgical centres segment is the fastest growing market, which is expected to grow at a cagr of 5.81% during the forecast period 2018 - 2023. stabilized hyaluronic acid segment accounted for the larger market share in 2017, this market is expected to reach usd 292.91 million in 2023 from usd 210.14 million in 2017. this market is projected to grow at a cagr of 5.75% during the forecast period from 2018 - 2023. however, stabilized hyaluronic acid segment is the fastest growing market, which is expected to grow at a cagr of 5.75% during the forecast period 2018 - 2023. three injection procedure segment accounted for the largest market share in 2017, this market is expected to reach usd 221.00 million in 2023 from usd 162.08 million in 2017. this market is projected to grow at a cagr of 5.35% during the forecast period from 2018 - 2023. however, single injection procedure segment is the fastest growing market, which is expected to grow at a cagr of 5.90% during the forecast period 2018 - 2023.